IRIS
MONNO, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.290
AS - Asia 5.125
EU - Europa 4.505
SA - Sud America 1.543
Continente sconosciuto - Info sul continente non disponibili 606
AF - Africa 316
OC - Oceania 3
AN - Antartide 1
Totale 27.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.971
SG - Singapore 1.977
IT - Italia 1.455
BR - Brasile 1.221
CN - Cina 1.051
HK - Hong Kong 878
DE - Germania 637
SE - Svezia 499
RU - Federazione Russa 412
UA - Ucraina 352
VN - Vietnam 339
FI - Finlandia 322
FR - Francia 264
GB - Regno Unito 255
IN - India 178
BD - Bangladesh 151
CI - Costa d'Avorio 134
CA - Canada 129
AR - Argentina 105
ID - Indonesia 91
IQ - Iraq 68
BE - Belgio 57
ZA - Sudafrica 57
EC - Ecuador 54
MX - Messico 54
CO - Colombia 48
IE - Irlanda 48
TR - Turchia 47
VE - Venezuela 45
PK - Pakistan 43
SA - Arabia Saudita 42
LT - Lituania 30
JP - Giappone 29
IL - Israele 27
NL - Olanda 27
PL - Polonia 27
UZ - Uzbekistan 27
AT - Austria 26
CR - Costa Rica 25
KE - Kenya 24
PH - Filippine 24
MA - Marocco 21
MY - Malesia 20
CL - Cile 18
ES - Italia 18
TN - Tunisia 18
NI - Nicaragua 17
PY - Paraguay 17
JO - Giordania 16
TT - Trinidad e Tobago 15
AE - Emirati Arabi Uniti 13
CW - ???statistics.table.value.countryCode.CW??? 13
DZ - Algeria 13
EG - Egitto 13
GR - Grecia 12
HR - Croazia 12
IR - Iran 12
SV - El Salvador 12
AZ - Azerbaigian 11
JM - Giamaica 11
PE - Perù 11
GP - Guadalupe 10
HN - Honduras 10
BO - Bolivia 9
GT - Guatemala 9
NP - Nepal 9
RS - Serbia 9
UY - Uruguay 9
KZ - Kazakistan 8
TH - Thailandia 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
LB - Libano 7
OM - Oman 7
PS - Palestinian Territory 7
AL - Albania 6
GE - Georgia 6
PA - Panama 6
PR - Porto Rico 6
ET - Etiopia 5
KW - Kuwait 5
CH - Svizzera 4
HU - Ungheria 4
KR - Corea 4
LY - Libia 4
PT - Portogallo 4
SC - Seychelles 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
EU - Europa 3
GY - Guiana 3
TW - Taiwan 3
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CM - Camerun 2
Totale 26.756
Salva come PNG Salva come JPEG
Città #
Fairfield 1.825
Ashburn 1.666
Woodbridge 1.179
Singapore 1.047
San Jose 894
Hong Kong 876
Chandler 809
Houston 800
Jacksonville 769
Seattle 722
Wilmington 625
Cambridge 598
Milan 530
Ann Arbor 454
Nyköping 364
Council Bluffs 328
Beijing 302
New York 231
Roxbury 227
Lawrence 224
Nanjing 205
Lauterbourg 197
Rome 196
Princeton 141
Los Angeles 140
São Paulo 135
Abidjan 134
Boardman 133
Des Moines 127
Santa Clara 125
Dallas 124
Helsinki 121
Ho Chi Minh City 90
San Diego 81
Bari 78
Munich 73
Hanoi 70
Shenyang 66
Dong Ket 65
Inglewood 65
Buffalo 56
Brooklyn 55
Columbus 54
London 50
Nanchang 50
Hebei 49
Jakarta 49
Figino 48
Rio de Janeiro 48
Dublin 47
Chicago 37
Turin 37
Brussels 35
Jiaxing 34
Tianjin 34
Toronto 33
Tokyo 28
The Dalles 27
Baghdad 26
Johannesburg 26
Atlanta 25
Curitiba 25
Frankfurt am Main 25
Paris 25
Nuremberg 24
Montreal 22
Moscow 22
Naples 22
San Francisco 22
Tashkent 22
Vilnius 22
Mexico City 21
Norwalk 21
Taranto 21
Warsaw 21
Belo Horizonte 20
Nairobi 20
San José 20
Turku 20
Changsha 18
Mumbai 18
Orem 18
Quito 18
Brasília 17
Campinas 17
Denver 17
Lahore 17
Phoenix 17
Guayaquil 16
Medellín 16
North Bergen 16
Pune 16
Riyadh 16
Washington 16
Dhaka 15
Falls Church 15
Florence 15
Managua 15
Bologna 14
Caracas 14
Totale 18.420
Salva come PNG Salva come JPEG
Nome #
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 399
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 377
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 235
Access to health services for undocumented immigrants in Apulia. 221
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 219
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 217
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 211
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 206
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 200
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 197
An outbreak of HIV-1 BC recombinants in Southern Italy 195
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence 188
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 188
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review 187
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 187
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 186
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 180
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 178
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 177
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 176
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence 176
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 176
Amoebic hepatic abscesses in an HIV-positive patient 173
The elderly and direct antiviral agents: Constraint or challenge? 171
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 170
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 169
Prevalence and Clinical Characteristics of Mycobacterial Diseases in the Barletta-Andria-Trani Province, Italy (2005-2013) 168
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 166
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 165
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 164
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 164
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 163
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 163
HIV tropism and its relationship with transmitted resistance in naive patients 162
Infection caused by Sporothrix schenckii: an autochthonous case in Bari, Southern Italy 162
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 161
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 158
Liver abscess due to Fusobacterium necrophorum in an immunocompetent patient 157
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 156
Access to Health Services for Undocumented Immigrants in Apulia 156
Co-receptor switch during HAART is independent of virological success 156
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review 156
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 156
A rigorous statistical learning method for the estimation and validation of weighted drug susceptibility scores applied to in vivo virological outcome prediction of atazanavir/ritonavir containing HAART 155
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 154
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 154
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique 153
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 153
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 152
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 148
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 148
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 148
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique 148
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 146
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study 146
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 145
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression 145
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide 144
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 143
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 143
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy. 142
Are the proposed env mutations actually associated with resistance to maraviroc? 141
Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders. 141
Liver abscess due to Fusobacterium necrophorum in an immunocompetent patient. A case report and review of the literature 140
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) 139
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy. 139
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique. 138
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 138
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 137
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 137
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 137
High HIV-1 diversity in immigrants resident in Italy (2008–2017) 137
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 136
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 136
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 135
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 134
Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy 133
Analisi della cinetica replicativa in cultura primaria di isolati di HIV-1 da soggetti in vario stadio di malattia 133
Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis 132
Pathways of care for HIV infected children in Beira, Mozambique: Pre-post intervention study to assess impact of task shifting 132
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 131
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients. 131
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 130
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 129
Tuberculosis and diabetes: Current state and future perspectives 129
Uncommon testicular localization of Disseminated TB: a case report from Mozambique 129
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 129
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 128
Effects of HIV superinfection on HBV replication in a chronic HbsAg carrier with liver disease 127
Intracellular and cell-free (infectious) HIV-1 in rectal mucosa 127
Association between HIV p24 antigen in cerebrospinal fluid and severe complications in the central nervous system 126
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 126
Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate 125
Drug Resistance Mutations and Newly Recognized Treatment-Related Substitutions in the HIV-1 Protease Gene: Prevalence and Associations With Drug Exposure and Real or Virtual Phenotypic Resistance to Protease Inhibitors in Two Clinical Cohorts of Antiretroviral Experienced Patients 125
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort. 123
Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals 122
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy. 121
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 121
Diagnosi sierologica dell'epatite acuta da virus A. Messa a punto e valutazione di tre metodiche per la determinazione delle IgM specifiche anti-HAV 120
Association between HLA class II antigens and hepatitis C virus infection 118
Totale 15.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.058 0 0 0 0 60 115 70 113 95 94 199 312
2022/20232.278 407 177 113 203 282 312 25 245 405 19 45 45
2023/2024832 68 163 45 48 71 212 29 21 21 23 30 101
2024/20253.379 41 64 360 121 72 309 251 285 166 176 483 1.051
2025/20267.428 975 555 528 808 642 351 829 216 689 708 222 905
2026/20272.259 164 375 574 1.048 98 0 0 0 0 0 0 0
Totale 27.389